Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies

Size: px
Start display at page:

Download "Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies"

Transcription

1 Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies Urs P. Mosimann, M.D., Elise N. Rowan Ph.D., Cassie E. Partington, M.Phil., Daniel Collerton M.Sc., Elizabeth Littlewood, B.Sc., John T. O Brien M.D., David J. Burn, M.D., Ian G. McKeith, M.D. Objective: Parkinson disease dementia (PDD) and dementia with Lewy bodies (DLB) have overlapping clinical and pathologic features. Recurrent visual hallucinations (RVH) are common in both disorders. The authors have compared details of hallucination characteristics and associated neuropsychiatric features in DLB and PDD. Methods: This is a descriptive, cross-sectional study using the Institute of Psychiatry Visual Hallucinations Interview (IP-VHI) to explore self-reported frequency, duration, and phenomenology of RVH in PDD and DLB. The caregivers ratings of hallucinations and other neuropsychiatric features were elicited with the Neuropsychiatric Inventory (NPI). Results: Fifty-six patients (35 PDD; 21 DLB) with RVH were assessed. Hallucination characteristics were similar in both disorders. Simple hallucinations were rare. Most patients experienced complex hallucinations daily, normally lasting minutes. They commonly saw people or animals and the experiences were usually perceived as unpleasant. NPI anxiety scores were higher in PDD. Neuropsychiatric symptoms coexisting with hallucinations were apathy, sleep disturbance, and anxiety. Conclusions: Patients with mild to moderate dementia can provide detailed information about their hallucinations. Characteristics of RVH were similar in PDD and DLB, and phenomenology suggests the involvement of dorsal and ventral visual pathways in their generation. The coexistence of RVH with anxiety, apathy, and sleep disturbance is likely to impair patients quality of life and may have treatment implications. (Am J Geriatr Psychiatry 2006; 14: ) Key Words: Visual hallucinations, dementia with Lewy bodies, Parkinson disease dementia Parkinson disease dementia (PDD) is a common late feature of Parkinson disease. It has overlapping pathologic and clinical features with dementia with Lewy bodies (DLB). 1,2 Lewy body pathology is prominent in both disorders, 3 and comparative studies have found no major differences in fluctuation of Received November 5, 2004; revised April 12, 2005; accepted April 19, From the Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom (UPM, ENR, CEP, EL, JTO, DJB, IGM), and Bensham Hospital, Gateshead, United Kingdom (DC). Send correspondence and reprint requests to Dr. Urs P. Mosimann, Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, U.K. u.p.mosimann@ncl.ac.uk 2006 American Association for Geriatric Psychiatry Am J Geriatr Psychiatry 14:2, February

2 Visual Hallucinations in Dementia attention, 4 phenomenology of parkinsonism, 5 autonomic dysfunction, 6 and response to cholinergic therapy. 7,8 The current clinical distinction of PDD and DLB therefore relies mainly on the duration of parkinsonism before dementia onset. Recurrent visual hallucinations (RVH) are prevalent (60% 80%) in PDD and DLB. 1,2 They are, together with fluctuation and parkinsonism, core clinical features of DLB. 9 The few studies addressing hallucination phenomenology in both disorders have reported well-formed complex hallucinations of people, animals, or objects 10,11 but do not mention simple hallucinations of flashes, dots, or grids, commonly mentioned in eye disease. 12 Hallucination phenomenology may thus be disease-dependent and may depend on the pattern of cortical dysfunction. The latter is supported by neuroimaging studies that related hallucination phenomenology to the activation of specific cortical visual areas, e.g., the hallucination of faces was accompanied with the activation of cortical areas involved in face perception. 13,14 Given the similar perfusion changes in areas involved in visual processing, 15 similar perceptual impairments, 16 and the lack of differences in hallucination phenomenology in previous studies, 10,11 we did not expect major differences in hallucination characteristics between PDD and DLB. To date, there have been no comparative studies of detailed hallucination characteristics in PDD and DLB using the same questionnaire. This pilot study therefore used the Institute of Psychiatry Visual Hallucinations Interview (IP-VHI) 12 in both disorders. As a result of the lack of a validated questionnaire to assess hallucinations in dementia, we chose an interview previously used to assess hallucinations and eye disease. A patient interview was important, because hallucinations are subjective percepts and we were interested in establishing whether demented patients could provide phenomenologic information. The Neuropsychiatric Inventory (NPI) 17 was used to assess the caregivers reports of hallucinations and associated neuropsychiatric features. Using this inventory, previous studies found highest scores for depression, apathy, and hallucinations in PDD 10 and apathy, delusions, and hallucinations in DLB. 18 Given these differences, we hypothesized that associated neuropsychiatric features in patients with PDD and those with DLB would slightly differ. METHODS Participants All patients in the Newcastle Medical Research Council (MRC) Lewy body patient cohort with PDD or DLB 5 were asked whether they experienced RVH at their annual assessment. Visual hallucinations were defined as visual perceptions without adequate visual stimulus. 19 To be included in this study, patients had to report RVH and the informant had to complete the NPI. Fifty-six of 85 patients reported RVH. DLB was diagnosed according to Consensus guidelines 9 and patients with PDD fulfilled U.K. Parkinsons Disease Society Brain Bank Clinical Diagnostic Criteria for PD for at least 12 months, before then fulfilling Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for dementia and for DLB. 20 Diagnosis was determined by the consensus of three senior clinicians (IGM, JTO, DJB) using a method with established accuracy as determined by autopsy confirmation. 21 The only antiparkinsonian medication allowed was L-dopa monotherapy. Patients taking cholinesterase inhibitors (ChE-Is) were eligible for the study provided they had been on a stable dose for more than three months. This requirement was mainly to avoid additional research appointments during the initial treatment phase. The local research ethics committee granted approval, procedures were fully explained to patients and informants, and both gave written informed consent. Testing Procedure The IP-VHI 12 is a semistructured patient interview that explores hallucination characteristics in detail and builds on well-established neurophysiological models. 22 It was originally developed for telephone interviewing of visually impaired patients with hallucinations, i.e., Charles Bonnet Syndrome (CBS). We adapted it slightly for the use in our sample, i.e., we assessed patients face to face in the outpatient clinic and patients were encouraged to give verbatim statements about their experiences. Verbatim statements were categorized by consensus (CEP, ENR, UPM) as simple hallucinations (e.g., flashes, lines, zigzags, regular and irregular patterns, particles) or wellformed complex hallucinations. The latter were 154 Am J Geriatr Psychiatry 14:2, February 2006

3 Mosimann et al. grouped into the following categories: children and babies, adult family members and friends, soldiers and anonymous people, animals, machines, body parts, or letters/numbers. An outline of the questionnaire can be found in the Appendix of Santhouse et al. 12 Interviewers were not blind with regard to diagnosis. The NPI is a caregiver interview assessing delusions, hallucinations, agitation, depression, anxiety, elation, apathy, disinhibition, irritability, aberrant motor behavior, sleep, and appetite. The subquestions Does the patient talk to people who are not there and Does the patient describe seeing things not seen by others of the hallucination section were used to establish if the caregiver confirmed the presence of RVH. 17 Fluctuation was measured with the Caregiver One-Day Fluctuation Assessment Scale. 23 The Bristol Activities of Daily Living Scale (Bristol ADL) 24 was used to assess functional impairment. These three caregiver assessments were completed in the absence of the patient. The Unified Parkinsons Disease Rating Scale (UPDRS) motor section (part III) 25 and Cambridge Cognitive Examination (CAMCOG) 26 were used to quantify the severity of extrapyramidal features and global cognitive impairments, respectively. Statistical Analysis Data were analyzed using the Statistical Package for Social Sciences (SPSS version 11). The distribution of the data were examined for normality (Kolmogorov Smirnov test). Means and standard deviations (SDs) were calculated. Provided the data did not deviate from the normal distribution, parametric tests (i.e., independent-sample t-tests) were used; nonnormally distributed data were compared with Mann-Whitney U tests. Pearson chi-square was used for the comparison of frequencies and Fisher exact tests when the expected frequency of a symptom in either group was 5. All reported p values are twotailed and a p value of less than 0.05 was considered significant. RESULTS Characteristics of the sample are summarized in Table 1. Fifty-six patients (35 PDD and 21 DLB) reported RVH. The two diagnostic groups did not differ with respect to age, gender, education, cognitive scores, fluctuation or the severity of parkinsonism. The onset of parkinsonism was, as expected, earlier in the PDD group. Ninety-one percent of patients with PDD were treated with L-dopa compared with only 29% of patients with DLB (Fisher exact: p ). Fifty-seven percent of patients with DLB were taking ChE-I compared with 31% of patients with PDD (Fisher exact: p 0.092). No differences in frequency, duration, or phenomenology of RVH were found between patients who were taking L-dopa and/or ChE-I and those not on these medications. TABLE 1. Characteristics of the Sample PDD DLB Comparison Statistic [df]; p Gender (M:F) 24:11 15:6 p 0.822* Age (years) t [54] 0.980, p Education (years) z [56] 0.836, p CAMCOG (maximum 105) t [51] 0.273, p MMSE (maximum 30) t [54] 0.878, p Age of dementia onset (years) t [43] 1.729, p UPDRS motor III (maximum 108) t [54] 0.978, p Age at EPS onset (years) t [43] 2.266, p NPI (maximum 144) t [54] 0.541, p Age at hallucination onset (years) t [39] 0.089, p Fluctuation scale (maximum 21) t [53] 1.607, p Bristol ADL (maximum 60) t [53] 0.410, p Means and standard deviations (SDs). *Fisher exact test. Mann Whitney U test, if not specified, independent-sample t-tests. CAMCOG: Cambridge Cognitive Examination; MMSE: Mini- Mental Status Examination; UPDRS: Unified Parkinsons Disease Rating Scale; NPI: Neuropsychiatric Inventory; PDD: Parkinson disease dementia; DLB: dementia with Lewy bodies. Am J Geriatr Psychiatry 14:2, February

4 Visual Hallucinations in Dementia Institute of Psychiatry Visual Hallucinations Interview Six patients (five PDD and one DLB) admitting to RVH were unable to complete the IP-VHI. The main characteristics of the remaining 50 patients (30 PDD and 20 DLB) are summarized in Table 2. Experiences of simple hallucinations in isolation were rare. RVH were commonly complex, experienced on a daily basis and lasting minutes rather than seconds or hours. Patients generally saw single, colored objects perceived in the central field of view. Hallucinated objects were static in more than 50% of cases. In addition to the main characteristics summarized in Table 2, the IP-VHI revealed that most hallucinations were opaque (PDD: 57%; DLB: 75%) rather than transparent (PDD: 37%; DLB: 10%) (Fisher exact test: p 0.088) and that hallucinations were constant (PDD: 70%; DLB: 80%) rather than changing from one thing into another (PDD: 13%; DLB: 0%) (Fisher exact test: p 0.143). Temporal palinopsia, i.e., the perseveration of a previously viewed object after a certain time, was reported in 47% of the patients with PDD and 25% of the patients with DLB (Fisher exact test: p 0.079). Spatial palinopsia, the persistence of a visual image in space, was found in 43% of the patients with PDD and 25% of the patients with DLB (Fisher exact test: p 0.129). Hallucinations were rarely precipitated by motion, e.g., by traveling in a car or train (PDD and DLB: both 10%), and they rarely moved with eye or head movements (PDD: 43%; DLB: 25%) (Fisher exact test: p 0.510). RVHs were sensitive to blinking in 40% of the patients with PDD and 30% of the patients with DLB (Fisher exact test: p 0.535) and persisted with closed eyes in 37% of the patients with PDD and 40% of patients with DLB (Fisher exact test: p 0.757). Patients normally found their hallucinations unpleasant (PDD: 43%; DLB: 45%) rather than pleasant (PDD: 3%; DLB: 10%) (Fisher exact test: p 0.565). Of patients with complex RVH (N 47), three patients (one PDD and two DLB) confirmed complex visual hallucinations by straightforward yes/no questions from the IP-VHI but were unable to give detailed descriptions of what they saw. Forty-four patients with complex visual hallucinations gave verbatim statements summarized in Table 3. Nearly two-thirds (63.6%) of the verbatim descriptions fell into more than one descriptive category. Patients reports most commonly referred to people or animals and machines. The nine patients who admitted RVH but were unable to complete the IP-VHI (N 6) or to give verbatim statements (N 3) were more cognitively impaired than patients giving a verbatim description of their hallucinations (MMSE versus ; independent-sample t-test: t 3.254, df 51, p 0.002). TABLE 2. Characteristics of Recurrent Visual Hallucinations of All Patients (30 PDD, 20 DLB) Completing the IP-VHI PDD N (%) DLB N (%) Comparison Statistic [df ]; p Hallucinations Simple 1 (3.3) 2 (10.0) Complex 16 (53.3) 14 (70.0) 2 [2] 3.366, p Simple and complex 13 (43.3) 4 (20.0) Frequency Continuous 4 (13.3) 2 (10.0) Daily 16 (53.3) 9 (45.0) 2 [3] 1.939, p Weekly 5 (16.7) 3 (15.0) Monthly 4 (13.3) 6 (30.0) Duration Seconds 6 (20.0) 4 (20.0) Minutes 16 (53.3) 10 (50.0) 2 [2] 0.158, p Hours 6 (20.0) 5 (25.0) Spatial frame Single object 19 (63.3) 18 (90.0) p 0.061* Extended scene 8 (26.7) 1 (5.0) Color in color 18 (60.0) 12 (60.0) p 1.000* Location Central field 20 (66.7) 12 (60.0) p 0.522* Peripheral field 7 (23.3) 7 (35.0) Motion In motion 12 (40.0) 6 (30.0) p 0.374* Statistics are Pearson chi-square ( 2 ) test or *Fisher exact tests. PDD: Parkinson disease dementia; DLB: dementia with Lewy bodies; IP-VHI: Institue of Psychiatry Visual Hallucinations Interview. 156 Am J Geriatr Psychiatry 14:2, February 2006

5 Mosimann et al. TABLE 3. Phenomenology of Complex Hallucinations (28 PDD, 16 DLB) Listed in Order of Frequency of Occurrence PDD N (%) DLB N (%) Fisher Exact Tests: p Values Examples Anonymous people/soldiers 17 (60.7) 11 (68.8) Figures sitting and standing in the house, sometimes blocking stairway; a group of people having a party; people walking in the bedroom; a line of nuns waiting to cross the road; gypsies walking around; medieval figures dressed in cloaks; a soldier on a navy ship; army marching up the lawn; gruesome elderly people without eyes; groups of people with distorted faces Friends, family members 8 (28.6) 3 (18.8) Son sitting in a chair in the living room; son climbing out of a window; mother and daughter speaking; deceased sister Children/babies 4 (14.3) 3 (18.8) Small boy in the bedroom shouting fire; children in bedroom cutting the bed clothes; groups of children running around Body parts 6 (21.4) 4 (25.0) Relative s faces; a shadowy face without a body; the head of a vicious dog; three faces moving together; a ghostly phantom without a head; three-legged people; an unpleasant, red-painted face of a cartoon character without a body; heads of known people in lounge; bodies in bedroom; distorted faces Animals 13 (46.4) 4 (25.0) Mice, rats and mice running along the skirting board; little animals, e.g., snakes on bed linen, hedgehogs in garden, and furry things on the floor; small spiders on the ceiling or the floor Machines (car, buses, airplanes) 7 (25.0) 2 (12.5) Buses and lorries; vehicles as part of a procession; a small gray van moving; flying in an airplane; gypsies dismantling wheels from a machine Letters 4 (14.3) 0 (0.0) Letters on the door; musical stave; musical notes; floating numbers PDD: Parkinson disease dementia; DLB: dementia with Lewy bodies. Neuropsychiatric Inventory The informants reports of neuropsychiatric symptoms are summarized in Figure 1. NPI scores (frequency multiplied by severity) did reveal differences between PDD and DLB; patients with PDD were more anxious than patients with DLB (Mann-Whitney z 2.606, N 56, p 0.009). Elation was uncommon, only being observed in three patients with DLB (Mann-Whitney z 2.277, N 56, p 0.023). No significant difference in anxiety scores was found when patients on ChE-I were compared with those off ChE-I in the PDD (Mann-Whitney z 1.147, N 35, p 0.283) and DLB groups (Mann-Whitney z 0, N 21, p 1.0). Other common symptoms, reported in more than 50% of the patients, were apathy and sleep problems. Most but not all (83.9%) informants confirmed hallucinations. Three-fourths of the caregivers were spouses, 16% were other relatives, and 9% were professional caregivers; and there was no difference in terms of caregiver type between informant-confirmed and -nonconfirmed RVH (chisquare 3.875, df 2, p 0.145). DISCUSSION This study assessed the characteristics of RVH in patients with PDD and DLB. The groups did not differ in age, gender, or dementia severity, and patients with mild to moderate dementia (MMSE 13) were able to provide phenomenologic information. Characteristics of RVH in DLB and PDD were similar. NPI scores for anxiety were higher in patients with PDD. Other common symptoms coexisting with hallucinations in both disorders were apathy and sleep disturbance. In agreement with previous studies, 10,11 most patients with PDD and those with DLB reported complex hallucinations of people, animals, Am J Geriatr Psychiatry 14:2, February

6 Visual Hallucinations in Dementia FIGURE 1. Summary of NPI Scores in Patients with PDD and Those With DLB With RVH Note: Patients with PDD were more anxious than patients with DLB (Mann-Whitney z 2.606, N 56, p 0.009), and elation was only observed in three patients with DLB (Mann-Whitney z 2.277, N 56, p 0.023). Other common symptoms coexisting with hallucinations were apathy and sleep disturbance. NPI: Neuropsychiatry Inventory; PDD: Parkinson disease dementia; DLB: dementia with Lewy bodies; RVH: recurrent visual hallucinations. and objects. Simple hallucinations, i.e., flashes, lines, or patterns, solely or in combination with complex hallucinations, were uncommon (up to 20%). Santhouse et al. 12 assessed 32 visually impaired patients with RVH, i.e., CBS, using the same questionnaire and found simple hallucinations in 80% of their cases. This supports the assumption that simple hallucinations are more common in CBS and may imply that different mechanisms are involved in the generation of simple and complex hallucinations. 27 Previous neuroimaging studies have linked the occurrence of complex hallucinations to the activation of specific, specialized cortical areas. 13,14 Two interconnected visual pathways are involved in 158 Am J Geriatr Psychiatry 14:2, February 2006

7 Mosimann et al. higher visual processing 28 ; the ventral visual pathway is for the recognition of colors, people, and objects and the dorsal pathway for motion and overview vision. 12,22 Bearing this in mind, hallucination phenomenology in PDD and DLB suggests involvement of both pathways, because patients perceived colors, detailed objects and people, as well as motion and scenery. The lack of differences between PDD and DLB may indicate similarities in their pathophysiology. This is supported by neuroimaging studies showing similar hypoperfusion in parietal 15 and occipital brain areas 29 and the profound neurodegeneration in visual association areas in DLB and PDD. 3 Hallucinations were commonly associated with sleep disturbances, apathy, and anxiety. Whether anxiety precipitates hallucinations, simply coexists, or is a consequence of them cannot be answered with the current data. That patients considered their hallucinations as unpleasant rather than pleasant tends to support the latter assumption. 30 Patients with PDD were more anxious than patients with DLB. Because it has been shown that cholinesterase inhibitors (ChE-I) can improve anxiety in DLB, 8 higher anxiety scores in PDD could be related to fact that fewer patients with PDD were treated with ChE-I. Nevertheless, no differences were found when anxiety scores of patients on and off ChE-Is were compared in either the PDD or the DLB groups, and this makes the difference in ChE-I intake an unlikely explanation for higher anxiety scores in PDD. The IP-VHI was helpful for assessing hallucination characteristics in mildly to moderately demented patients; however, it was less effective for severely impaired patients. Patients with MMSE below 13 had difficulties providing phenomenologic information. To assess their experiences, it is therefore also necessary to question their caregivers. Unfortunately, no existing patient hallucination questionnaire has a parallel caregiver version. The extent to which caregivers can provide additional phenomenologic information needs further evaluation because in the present study, 16% of the caregivers were unaware of patients RVH. A limitation that needs to be recognized when interpreting these findings is that the psychometric properties (validity or reliability measures) of IP-VHI are unknown. This is unfortunately a general limitation for all hallucination questionnaires published so far. Another limitation in the present study is that we cannot exclude a type II error to be the reason for a lack of difference in hallucination characteristics in PDD and DLB. To our knowledge, this is the biggest, most detailed characterization of visual hallucinations in PDD and DLB to date, but the sample size is still relatively small. Considering present and previous data, 11,31 it is unlikely that hallucination content will be helpful for distinguishing PDD from DLB. Diagnosis of DLB in the current study was based on clinical guidelines using the duration of Parkinson disease before cognitive impairment to separate DLB from PDD. 9 This method has been proven accurate in previous longitudinal studies with autopsy confirmation 21 but does not completely exclude clinical misdiagnosis. Finally, only patients freely admitting RVH were included in our analysis, and thus it is possible that a selection bias was introduced by inadvertently excluding patients not disclosing them. This pilot study suggests similarities in hallucination characteristics in PDD and DLB and demonstrates the strength and limitations of existing methods for hallucination assessment. The lack of differences in hallucination phenomenology suggests similar disturbances in the visual system in the two disorders. Refined questionnaires with established psychometric properties and parallel caregiver versions are needed to quantify visual hallucinations and quantify treatment benefits. Support of this work has been provided in part by the U.K. Medical Research Council (IGM, JTO, DJB) and by the Swiss National Science Foundation and Swiss Association for Parkinsons disease (UPM). The authors thank patients and informants who made this work possible and Nicola Barnett and Debra Lett for their invaluable help with recruiting. Many thanks to Dr. D. Ffytche and Professor R. J. Howard of the Institute of Psychiatry in London for providing us with their questionnaire. References 1. McKeith I, Mintzer J, Aarsland D, et al: Dementia with Lewy bodies. Lancet Neurol 2004; 3: Emre M: Dementia associated with Parkinson s disease. Lancet Neurol 2003; 2: Am J Geriatr Psychiatry 14:2, February

8 Visual Hallucinations in Dementia 3. Harding AJ, Broe GA, Halliday GM: Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: Ballard CG, Aarsland D, McKeith I, et al: Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 2002; 59: Burn DJ, Rowan EN, Minett T, et al: Extrapyramidal features in Parkinson s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 2003; 18: Wenning GK, Scherfler C, Granata R, et al: Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999; 67: Emre M, Aarsland D, Albanese A, et al: Rivastigmine for dementia associated with Parkinson s disease. N Engl J Med 2004; 351: McKeith I, Del Ser T, Spano P, et al: Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebocontrolled international study. Lancet 2000; 356: McKeith IG, Galasko D, Kosaka K, et al: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: Aarsland D, Cummings JL, Larsen JP: Neuropsychiatric differences between Parkinson s disease with dementia and Alzheimer s disease. Int J Geriatr Psychiatry 2001; 16: Ballard C, McKeith I, Harrison R, et al: A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer s disease. Int Psychogeriatr 1997; 9: Santhouse AM, Howard RJ, Ffytche DH: Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000; 123: Howard R, David A, Woodruff P, et al: Seeing visual hallucinations with functional magnetic resonance imaging. Dement Geriatr Cogn Disord 1997; 8: Ffytche DH, Howard RJ, Brammer MJ, et al: The anatomy of conscious vision: an fmri study of visual hallucinations. Nat Neurosci 1998; 1: Firbank MJ, Colloby SJ, Burn DJ, et al: Regional cerebral blood flow in Parkinson s disease with and without dementia. Neuroimage 2003; 20: Mosimann UP, Mather G, Wesnes K, et al: Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004; 63: Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: Del Ser T, McKeith I, Anand R, et al: Dementia with Lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry 2000; 15: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson s disease. J Neurol Neurosurg Psychiatry 1988; 51: McKeith IG, Ballard CG, Perry RH, et al: Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54: Girkin CA, Miller NR: Central disorders of vision in humans. Surv Ophthalmol 2001; 45: Walker MP, Ayre GA, Cummings JL, et al: The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000; 177: Bucks RS, Ashworth DL, Wilcock GK, et al: Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25: Fahn S, Elton R, UPDRS Program Members: Unified Parkinson s Disease Rating Scale. Florham Park, NJ, Macmillan Healthcare Information, Roth M, Tym E, Mountjoy CQ, et al: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: Collerton D, Perry E, McKeith I: Why people see things that are not there. A novel perception and attention deficit model for recurrent complex visual hallucinations. Behavioural and Brain Sciences 2005; in press 28. Ungerleider LG, Haxby JV: What and where in the human brain. Curr Opin Neurobiol 1994; 4: Lobotesis K, Fenwick JD, Phipps A, et al: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: Collerton D, Dudley R: A cognitive behavioural framework for the treatment of distressing visual hallucinations in older people. Behavioural and Cognitive Psychotherapy 2004; 32: Aarsland D, Ballard C, Larsen JP, et al: A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson s disease with and without dementia. Int J Geriatr Psychiatry 2001; 16: Am J Geriatr Psychiatry 14:2, February 2006

A prospective study of dementia with Lewy bodies

A prospective study of dementia with Lewy bodies Age and Ageing 998; 27: 6-66 998, British Geriatrics Society A prospective study of dementia with Lewy bodies CLIVE G. BALLARD, JOHN O'BRIEN, KATH LOWERX GARETH A. AYRE, RICHARD HARRISON, ROBERT PERRY,

More information

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview

More information

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients Blackwell Science, LtdOxford, UKPCNPsychiatry and Clinical Neurosciences1323-13162005 Blackwell Publishing Pty Ltd593274279Original ArticleDementia and mild AlzheimersJ. Shimabukuro et al. Psychiatry and

More information

Parkinsonian Disorders with Dementia

Parkinsonian Disorders with Dementia Parkinsonian Disorders with Dementia George Tadros Consultant in Old Age Liaison Psychiatry, RAID, Heartlands Hospital Professor of Dementia and Liaison Psychiatry, Aston Medical School Aston University

More information

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia Disclosures Research support, Parkinson Society Canada, Canadian Institutes of Health Research, Ministry of Economic Development and Innovation, Teva Novartis clinical trial, Principal Investigator CME

More information

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Review article: The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Dr. Ivan Netto 1, Aditya Iyer 2, Dr. Prathamesh

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

Range of neuropsychiatric disturbances in patients with Parkinson s disease

Range of neuropsychiatric disturbances in patients with Parkinson s disease 492 Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital D Aarsland N G Lim C Janvin Department of Neurology, Central Hospital of Rogaland, Stavanger, Norway J P Larsen K Karlsen E Tandberg Departments

More information

A wide range of neuropsychiatric disturbances commonly

A wide range of neuropsychiatric disturbances commonly 36 PAPER Neuropsychiatric symptoms in patients with Parkinson s disease and dementia: frequency, profile and associated care giver stress D Aarsland, K Brønnick, U Ehrt, P P De Deyn, S Tekin, M Emre, J

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

T he prevalence of Parkinson s disease (PD) is nearly 1% in

T he prevalence of Parkinson s disease (PD) is nearly 1% in 708 PAPER Donepezil for cognitive impairment in Parkinson s disease: a randomised controlled study D Aarsland, K Laake, J P Larsen, C Janvin... See end of article for authors affiliations... Correspondence

More information

ORIGINAL CONTRIBUTION. Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies

ORIGINAL CONTRIBUTION. Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies ORIGINAL CONTRIBUTION Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies John T. O Brien, DM, MRCPysch; Sean Colloby, MPhil; John Fenwick,

More information

Brain imaging for the diagnosis of people with suspected dementia

Brain imaging for the diagnosis of people with suspected dementia Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis

More information

ORIGINAL CONTRIBUTION. Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease

ORIGINAL CONTRIBUTION. Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease ORIGINAL CONTRIBUTION Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease Clive Ballard, MRCPsych, MD; John O Brien, MRCPsych, DM; Alistair Gray, BSc; Franchesca

More information

Title: Visual Hallucinations in Eye Disease and Lewy Body Disease

Title: Visual Hallucinations in Eye Disease and Lewy Body Disease Accepted Manuscript Title: Visual Hallucinations in Eye Disease and Lewy Body Disease Author: Prabitha Urwyler, Tobias Nef, René Müri, Neil Archibald, Selina Margaret Makin, Daniel Collerton, John-Paul

More information

University of Groningen. Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe

University of Groningen. Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe University of Groningen Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials

Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Alzheimer s & Dementia 4 (2008) 390 394 Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials Donald J. Connor a, *, Marwan N. Sabbagh a, Jeffery L. Cummings b a Cleo

More information

Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia

Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia STEER 2002; Vol 2: No.2 Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-alzheimer s dementia Bunmi Fajemisin Evidence search date: November 2001 www.signpoststeer.org

More information

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study

Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study Open Access To cite: Walker Z, McKeith I, Rodda J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer s disease: a cohort study. BMJ Open 2012;2:e000380. doi:10.1136/

More information

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there

More information

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Neuropsychiatric Inventory Nursing Home Version (NPI-NH)

Neuropsychiatric Inventory Nursing Home Version (NPI-NH) This is a Sample version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) The full version of the Neuropsychiatric Inventory Nursing Home Version (NPI-NH) comes without sample watermark..

More information

RICHARD J. ATHEY, ROBERT W. PORTER, RICHARD W. WALKER. Abstract. Introduction. R. J. Athey et al.

RICHARD J. ATHEY, ROBERT W. PORTER, RICHARD W. WALKER. Abstract. Introduction. R. J. Athey et al. R. J. Athey et al. Age and Ageing 2005; 34: 268 273 doi:10.1093/ageing/afi098 The Author 2005. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For

More information

Satoh M. 1, Ishikawa H. 1, Meguro K. 1,2, Kasuya M. 1, Ishii H. 3, and Yamaguchi S. 2

Satoh M. 1, Ishikawa H. 1, Meguro K. 1,2, Kasuya M. 1, Ishii H. 3, and Yamaguchi S. 2 CYRIC Annual Report 2009 VIII 15. Occipital Glucose Metabolic Decrease by Donepezil Treatment Correlated with the Improvement of Visual Hallucinations in Dementia with Lewy Bodies: the Osaki-Tajiri Project

More information

Known as both a thief and murderer,

Known as both a thief and murderer, &A Dementia Drugs: When Should They Be Stopped? Ron Keren, MD, FRCPC As presented at the University of Toronto s Primary Care Conference, Toronto, Ontario (May 25) Known as both a thief and murderer, Alzheimer

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

The relationship between hallucinations and FDG-PET in dementia with Lewy bodies

The relationship between hallucinations and FDG-PET in dementia with Lewy bodies The relationship between hallucinations and FDG-PET in dementia with Lewy bodies Michael J. Firbank, 1 Jim Lloyd, 2 John T. O Brien 3 1 Institute for Neuroscience and Newcastle University Institute for

More information

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies)

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies) Dementia with Lewy bodies First described: Okazaki H, 1961, Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables

The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2005; 20: 531 536. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/gps.1317 The course of neuropsychiatric

More information

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4 Management of Agitation in Dementia Kimberly Triplett Ferguson, MS4 Objectives 1. Review recommended evaluation of agitated patients with dementia. 2. Discuss evidence concerning nonpharmacologic management.

More information

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Debby Tsuang, MD, MSc, Kate Simpson, MPH, Eric B. Larson, MD, MPH, Elaine Peskind, MD, Walter Kukull,

More information

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic

Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Original Articles 179 Psychiatric Morbidity in Dementia Patients in a Neurology-Based Memory Clinic Ching-Sen Shih 1, Sui-Hing Yan 2, Ying-Hoo Ho 1, Yuh-Te Lin 1, Jie-Yuan Li 1, and Yuk-Keung Lo 1 Abstract-

More information

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

Diagnostic accuracy of 123 I-FP-CIT SPECT in possible dementia with Lewy bodies

Diagnostic accuracy of 123 I-FP-CIT SPECT in possible dementia with Lewy bodies The British Journal of Psychiatry (2009) 194, 34 39. doi: 10.1192/bjp.bp.108.052050 Diagnostic accuracy of 123 I-FP-CIT SPECT in possible dementia with Lewy bodies John T. O Brien, Ian G. McKeith, Zuzana

More information

Clinical prevalence of Lewy body dementia

Clinical prevalence of Lewy body dementia Kane et al. Alzheimer's Research & Therapy (2018) 10:19 https://doi.org/10.1186/s13195-018-0350-6 RESEARCH Open Access Clinical prevalence of Lewy body dementia Joseph P. M. Kane 1, Ajenthan Surendranathan

More information

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian

Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian Burden of behavioral and psychiatric symptoms in people screened positive for dementia in primary care results of the DelpHi-study René Thyrian German Center for Neurodegenerative Diseases (DZNE), site

More information

Nature, prevalence and clinical significance. Barcelona, Spain

Nature, prevalence and clinical significance. Barcelona, Spain Nature, prevalence and clinical significance Jaime Kulisevsky Barcelona, Spain 1 Non motor (neuropsychiatric) symptoms are an integral part of Parkinson s s disease (PD) Affective disorders And are associated

More information

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge Introduction, use of imaging and current guidelines John O Brien Professor of Old Age Psychiatry University of Cambridge Why do we undertake brain imaging in AD and other dementias? Exclude other causes

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Update on functional brain imaging in Movement Disorders

Update on functional brain imaging in Movement Disorders Update on functional brain imaging in Movement Disorders Mario Masellis, MSc, MD, FRCPC, PhD Assistant Professor & Clinician-Scientist Sunnybrook Health Sciences Centre University of Toronto 53 rd CNSF

More information

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia 86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile

More information

Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer s disease

Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer s disease J Neurol Neurosurg Psychiatry 2001;70:483 488 483 Center for Alzheimer Disease and Related Disorders, Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA

More information

Assessment Toolkits for Lewy Body Dementia

Assessment Toolkits for Lewy Body Dementia Study : Assessment Toolkits for Lewy Body Dementia There are two toolkits, depending on whether the patient is presenting with a primary cognitive problem or with cognitive decline in the context of established

More information

2015, DOI: /S

2015, DOI: /S Elder GJ, Firbank MJ, Kumar H, Chatterjee P, Chakraborty T, Dutt A, Taylor J- P. Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a

More information

PROFESSIONAL CONSIDERATIONS IN CHOOSING A TREATMENT FOR NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA PATIENTS

PROFESSIONAL CONSIDERATIONS IN CHOOSING A TREATMENT FOR NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA PATIENTS MASTER THESIS HEALTH SCIENCES PROFESSIONAL CONSIDERATIONS IN CHOOSING A TREATMENT FOR NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA PATIENTS M.A.C. HULSHOF, BSC FACULTY OF MANAGEMENT AND GOVERNANCE DEPARMENT OF

More information

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci. How to Diagnose Early (Prodromal) Lewy Body Dementia Ian McKeith MD, FRCPsych, F Med Sci. Parkinson s Disease Lewy Body Disease Time PD Dementia Lewy Body Dementias Dementia with Lewy Bodies (DLB) Diagnostic

More information

The Basics of Alzheimer s Disease

The Basics of Alzheimer s Disease 2017 Memory Loss Conference The Basics of Alzheimer s Disease Tom Ala, MD Center for Alzheimer s Disease and Related Disorders Southern Illinois University School of Medicine Springfield, Illinois SIU

More information

Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease

Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson s Disease Dag Aarsland, M.D., Ph.D. Irene Litvan, M.D. Jan P. Larsen, M.D., Ph.D. Neuropsychiatric symptoms are common

More information

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH EADC BRUNO VELLAS 14/01/05 10:14 Page 1 EADC OVERVIEW B. VELLAS & E. REYNISH (Toulouse, France, EU) Bruno Vellas: The European Alzheimer's Disease Consortium is a European funded network of centres of

More information

Coordinating Care Between Neurology and Psychiatry to Improve the Diagnosis and Treatment of Parkinson s Disease Psychosis

Coordinating Care Between Neurology and Psychiatry to Improve the Diagnosis and Treatment of Parkinson s Disease Psychosis Coordinating Care Between Neurology and Psychiatry to Improve the Diagnosis and Treatment of Parkinson s Disease Psychosis Jeff Gelblum, MD Senior Attending Neurologist Mt. Sinai Medical Center Miami,

More information

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish

More information

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B.

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. UvA-DARE (Digital Academic Repository) Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. Link to publication Citation for published version (APA): Post, B. (2009). Clinimetrics,

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

Non-motor symptoms as a marker of. Michael Samuel

Non-motor symptoms as a marker of. Michael Samuel Non-motor symptoms as a marker of progression in Parkinson s s disease Michael Samuel London, UK 1 Definitions and their problems Non-motor symptoms as a marker of progression Non-motor symptoms (NMS)

More information

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms State of the art lecture March 4-2012 Philippe H Robert, Philippe Nice - France Robert The diagnosis of AD Neuropsychiatric

More information

P20.2. Characteristics of different types of dementia and challenges for the clinician

P20.2. Characteristics of different types of dementia and challenges for the clinician P20.2. Characteristics of different types of dementia and challenges for the clinician, professor Danish Dementia Research Center Rigshospitalet, University of Copenhagen (Denmark) This project has received

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

Virtual Mentor American Medical Association Journal of Ethics August 2014, Volume 16, Number 8:

Virtual Mentor American Medical Association Journal of Ethics August 2014, Volume 16, Number 8: Virtual Mentor American Medical Association Journal of Ethics August 2014, Volume 16, Number 8: 626-630. STATE OF THE ART AND SCIENCE Use of Art Making in Treating Older Patients with Dementia Laura T.

More information

Introduction to Dementia: Complications

Introduction to Dementia: Complications Introduction to Dementia: Complications Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:

More information

BEHAVIORAL PROBLEMS IN DEMENTIA

BEHAVIORAL PROBLEMS IN DEMENTIA BEHAVIORAL PROBLEMS IN DEMENTIA CLINICAL FEATURES Particularly as dementia progresses, psychiatric symptoms may develop that resemble discrete mental disorders such as depression or mania The course and

More information

Dementia: It s Not Always Alzheimer s

Dementia: It s Not Always Alzheimer s Dementia: It s Not Always Alzheimer s A Caregiver s Perspective Diane E. Vance, Ph.D. Mid-America Institute on Aging and Wellness 2017 My Background Caregiver for my husband who had Lewy Body Dementia

More information

University of Groningen. Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe

University of Groningen. Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe University of Groningen Visual hallucinations in Parkinson's disease Meppelink, Anne Marthe IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact

More information

MOVEMENT DISORDERS AND DEMENTIA

MOVEMENT DISORDERS AND DEMENTIA MOVEMENT DISORDERS AND DEMENTIA FOCUS ON DEMENTIA WITH LEWY BODIES MADHAVI THOMAS MD NORTH TEXAS MOVEMENT DISORDERS INSTITUTE, INC DEMENTIA de men tia dəˈmen(t)sh(ē)ə/ nounmedicine noun: dementia a chronic

More information

Dementia: How to explain the diagnosis to patients and relatives

Dementia: How to explain the diagnosis to patients and relatives GPHot Topics (April 2017): Dementia: How to explain the diagnosis to patients and relatives mohammad somauroo Consultant Physician with specialist interest in Community Geriatrics Royal Liverpool and Broadgreen

More information

Behavioral Aspects of Parkinson s Disease

Behavioral Aspects of Parkinson s Disease Behavioral Aspects of Parkinson s Disease Joseph H. Friedman, MD Director, Movement Disorders Program Butler Hospital Dept of Neurology Alpert Medical School of Brown University 1 Disclosures Drugs will

More information

The Neuropsychiatric Inventory Questionnaire: Background and Administration

The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire: Background and Administration The Neuropsychiatric Inventory Questionnaire (NPI-Q) was developed and crossvalidated with the standard NPI to provide a brief

More information

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT RUTH KOHEN ASSOCIATE PROFESSOR UW DEPARTMENT OF PSYCHIATRY 5-4-2017

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information

Dementia in Parkinson s disease:

Dementia in Parkinson s disease: Dementia in Parkinson s disease: A 20 year Prospective Neuropsychological Study Sydney Multicentre Study Associate Professor Wayne GJ Reid PhD FAPS 149 newly diagnosed community living Parkinson s Disease

More information

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review Dementia 1 Session outline Introduction to dementia Assessment of dementia Management of dementia Follow-up Review 2 Activity 1: Person s story Present a person s story of what it feels like to live with

More information

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA Unmet needs What might be your behavioural response to this experience? Content Definition What are BPSD? Prevalence How common are they? Aetiological

More information

Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review

Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review REVIEW ARTICLE Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review L. F. Morra and P. J. Donovick State University of New York at Binghamton, Binghamton, NY, USA Correspondence

More information

Non Alzheimer Dementias

Non Alzheimer Dementias Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

Rules of apparent motion: The shortest-path constraint: objects will take the shortest path between flashed positions.

Rules of apparent motion: The shortest-path constraint: objects will take the shortest path between flashed positions. Rules of apparent motion: The shortest-path constraint: objects will take the shortest path between flashed positions. The box interrupts the apparent motion. The box interrupts the apparent motion.

More information

Behavioural disabilities in psychogeriatric patients and residents of old people's homes

Behavioural disabilities in psychogeriatric patients and residents of old people's homes Journal of Epidemiology and Community Health, 1980, 34, 106-110 Behavioural disabilities in psychogeriatric patients and residents of old people's homes C. J. GILLEARD From the Department of Psychiatry,

More information

Clinical features of dementia with lewy bodies in 35 Chinese patients

Clinical features of dementia with lewy bodies in 35 Chinese patients Han et al. Translational Neurodegeneration 2014, 3:1 Translational Neurodegeneration RESEARCH Open Access Clinical features of dementia with lewy bodies in 35 Chinese patients Ding Han, Qiong Wang, Zhongbao

More information

Dementia Diagnosis Guidelines Primary Care

Dementia Diagnosis Guidelines Primary Care Dementia Diagnosis Guidelines Primary Care Dementia Diagnosis Primary Care Guidelines Introduction Dementia is a long term condition, which primarily affects people over the age of 65 (late on-set dementia)

More information

Cognitive Decline in Patients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type

Cognitive Decline in Patients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type Age and Ageing 1996.25:209-21 3 Cognitive Decline in atients with Alzheimer's Disease, Vascular Dementia and Senile Dementia of Lewy Body Type C. BALLARD, A. ATEL, F. OYEBODE, G. WILCOCK Summary One hundred

More information

Frontal Behavioural Inventory (FBI)

Frontal Behavioural Inventory (FBI) This is a Sample version of the Frontal Behavioural Inventory (FBI) The full version of the Frontal Behavioural Inventory (FBI) comes without sample watermark. The full complete version includes Complete

More information

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease What is PRESENTS DEMENTIA? WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: Memory Reasoning Planning Learning Attention Language Perception Behavior AS OF 2013 There

More information

Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes

Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes Town Hall Forum Making a Plan: The Smart Approach to Alzheimer s Care Needs May 25, 2017 Understanding the Progression of Alzheimer s and Related Dementias And Planning for Future Changes Daniel D. Sewell,

More information

Gerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION

Gerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry (2008) Published online in Wiley InterScience (www.interscience.wiley.com).2133 Cognitive, functional and behavioral factors associated

More information

Neurocognitive Disorders Research to Emerging Therapies

Neurocognitive Disorders Research to Emerging Therapies Neurocognitive Disorders Research to Emerging Therapies Edward Huey, MD Assistant Professor of Psychiatry and Neurology The Taub Institute for Research on Alzheimer s Disease and the Aging Brain Columbia

More information

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN Parkinson s Academy Registrar Masterclass Sheffield DIFFERENTIAL DIAGNOSIS SARAH MARRINAN 17 th September 2014 Objectives Importance of age in diagnosis Diagnostic challenges Brain Bank criteria Differential

More information

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study John-Paul Taylor, Michael Firbank, Nicola Barnett, Sarah Pearce, Anthea Livingstone, Urs Mosimann, Janet Eyre,

More information

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Baseline Characteristics of Patients Attending the   Memory Clinic Serving the South Shore of Boston Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,

More information

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018 Mary Ellen Quiceno, MD, FAAN Associate Professor of Neurology UNTHSC Center for Geriatrics 855 Montgomery Street, PCC 4, Ft.

More information

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why? Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric

More information

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

9/24/2012. Amer M Burhan, MBChB, FRCP(C) Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression

More information

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE Objectives At the conclusion of the session, participants will be

More information

Assessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia

Assessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia Assessment at the bedside or in the clinic using the history, examination and laboratory tests to distinguish between different types of dementia AP Passmore Content Common dementia syndromes (older people)

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Rachel Glick, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information